These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24962280)

  • 1. Design of anticancer lysophosphatidic acid agonists and antagonists.
    Parrill AL
    Future Med Chem; 2014 May; 6(8):871-83. PubMed ID: 24962280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysophosphatidic acid (LPA) receptor modulators: Structural features and recent development.
    Meduri B; Pujar GV; Durai Ananda Kumar T; Akshatha HS; Sethu AK; Singh M; Kanagarla A; Mathew B
    Eur J Med Chem; 2021 Oct; 222():113574. PubMed ID: 34126459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysophosphatidic acid and its receptors: pharmacology and therapeutic potential in atherosclerosis and vascular disease.
    Zhou Y; Little PJ; Ta HT; Xu S; Kamato D
    Pharmacol Ther; 2019 Dec; 204():107404. PubMed ID: 31472182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LPA and its analogs-attractive tools for elucidation of LPA biology and drug development.
    Kano K; Arima N; Ohgami M; Aoki J
    Curr Med Chem; 2008; 15(21):2122-31. PubMed ID: 18781939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysophosphatidic acid receptor agonists and antagonists (WO2010051053).
    Parrill AL
    Expert Opin Ther Pat; 2011 Feb; 21(2):281-6. PubMed ID: 21222547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alkyl lysophosphatidic acid and fluoromethylene phosphonate analogs as metabolically-stabilized agonists for LPA receptors.
    Xu Y; Tanaka M; Arai H; Aoki J; Prestwich GD
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5323-8. PubMed ID: 15454220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorothioate analogs of sn-2 radyl lysophosphatidic acid (LPA): metabolically stabilized LPA receptor agonists.
    Jiang G; Inoue A; Aoki J; Prestwich GD
    Bioorg Med Chem Lett; 2013 Mar; 23(6):1865-9. PubMed ID: 23395664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysophosphatidic acid (LPA) receptor-mediated signaling and cellular responses to anticancer drugs and radiation of cancer cells.
    Ikeda H; Takai M; Tsujiuchi T
    Adv Biol Regul; 2024 May; 92():101029. PubMed ID: 38377635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysophosphatidic acid stimulates cell growth by different mechanisms in SKOV-3 and Caov-3 ovarian cancer cells: distinct roles for Gi- and Rho-dependent pathways.
    Hurst JH; Hooks SB
    Pharmacology; 2009; 83(6):333-47. PubMed ID: 19420982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diverse effects of LPA receptors on cell motile activities of cancer cells.
    Tsujiuchi T; Hirane M; Dong Y; Fukushima N
    J Recept Signal Transduct Res; 2014 Jun; 34(3):149-53. PubMed ID: 24460191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LPA(3), a unique G protein-coupled receptor for lysophosphatidic acid.
    Hama K; Aoki J
    Prog Lipid Res; 2010 Oct; 49(4):335-42. PubMed ID: 20230855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysophosphatidic acid (LPA) and its receptors.
    Noguchi K; Herr D; Mutoh T; Chun J
    Curr Opin Pharmacol; 2009 Feb; 9(1):15-23. PubMed ID: 19119080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysophosphatidic Acid Receptor Antagonists and Cancer: The Current Trends, Clinical Implications, and Trials.
    Lin YH; Lin YC; Chen CC
    Cells; 2021 Jun; 10(7):. PubMed ID: 34209775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysophosphatidic acid receptors in cancer pathobiology.
    Tsujiuchi T; Araki M; Hirane M; Dong Y; Fukushima N
    Histol Histopathol; 2014 Mar; 29(3):313-21. PubMed ID: 24194373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unmasking of LPA1 receptor-mediated migration response to lysophosphatidic acid by interleukin-1β-induced attenuation of Rho signaling pathways in rat astrocytes.
    Sato K; Horiuchi Y; Jin Y; Malchinkhuu E; Komachi M; Kondo T; Okajima F
    J Neurochem; 2011 Apr; 117(1):164-74. PubMed ID: 21244430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysophosphatidic acid and its receptor LPA
    Srikanth M; Chew WS; Hind T; Lim SM; Hay NWJ; Lee JHM; Rivera R; Chun J; Ong WY; Herr DR
    Eur J Pharmacol; 2018 Dec; 841():49-56. PubMed ID: 30321532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LPA1 receptors mediate stimulation, whereas LPA2 receptors mediate inhibition, of migration of pancreatic cancer cells in response to lysophosphatidic acid and malignant ascites.
    Komachi M; Tomura H; Malchinkhuu E; Tobo M; Mogi C; Yamada T; Kimura T; Kuwabara A; Ohta H; Im DS; Kurose H; Takeyoshi I; Sato K; Okajima F
    Carcinogenesis; 2009 Mar; 30(3):457-65. PubMed ID: 19129242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development of modulators for lysophosphatidic acid receptors: A comprehensive review.
    Liu W; Hopkins AM; Hou J
    Bioorg Chem; 2021 Dec; 117():105386. PubMed ID: 34695732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of LPA receptor signaling in breast cancer.
    Wang J; Sun Y; Qu J; Yan Y; Yang Y; Cai H
    Expert Rev Mol Diagn; 2016 Oct; 16(10):1103-1111. PubMed ID: 27644846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous lysophosphatidic acid (LPA
    Sattikar A; Dowling MR; Rosethorne EM
    Br J Pharmacol; 2017 Feb; 174(3):227-237. PubMed ID: 27864940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.